AIM: To clarify the expression and role of Ephrin receptor A4 (EphA4) in gastric cancer in relation to clinicopathological characteristics and the expression of fibroblast growth factor receptor 1 (FGFR1) and ephrin ligands. METHODS: Eleven gastric carcinoma cell lines, 24 paired surgical fresh specimens of gastric adenocarcinoma and adjacent nontumor tissue, 74 conventional formalin-fixed, paraffin-embedded tumor specimens, and 55 specimens spotted on tissue microarray (TMA) were analyzed. Reverse transcription-PCR (RT-PCR), real-time RT-PCR, immunohistochemistry, and cell growth assays were performed. RESULTS: Overexpression of EphA4 mRNA expression was observed in 8 (73%) of 11 gastric cancer cell lines and 10 (42%) of 24 gastric cancer tissues. Overexpression of EphA4, analyzed by immunohistochemistry, was observed in 62 (48%) of 129 gastric cancer tissues. EphA4 overexpression, at the protein level, was significantly associated with depth of invasion and recurrence. EphA4 overexpression was also correlated with FGFR1 overexpression. Patients with EphA4-positive cancer had significantly shorter overall survival periods than did those with EphA4-negative cancer (P = 0.0008). The mRNAs for ephrin ligands were coexpressed in various combinations in gastric cancer cell lines and cancer tissues. Downregulation of EphA4 expression by siRNA in EphA4-overexpressing gastric cancer cell lines resulted in a significant decrease in cell growth. CONCLUSION: Our results suggest that overexpression of EphA4 plays a role in gastric cancer.
AIM: To clarify the expression and role of Ephrin receptor A4 (EphA4) in gastric cancer in relation to clinicopathological characteristics and the expression of fibroblast growth factor receptor 1 (FGFR1) and ephrin ligands. METHODS: Eleven gastric carcinoma cell lines, 24 paired surgical fresh specimens of gastric adenocarcinoma and adjacent nontumor tissue, 74 conventional formalin-fixed, paraffin-embedded tumor specimens, and 55 specimens spotted on tissue microarray (TMA) were analyzed. Reverse transcription-PCR (RT-PCR), real-time RT-PCR, immunohistochemistry, and cell growth assays were performed. RESULTS: Overexpression of EphA4 mRNA expression was observed in 8 (73%) of 11 gastric cancer cell lines and 10 (42%) of 24 gastric cancer tissues. Overexpression of EphA4, analyzed by immunohistochemistry, was observed in 62 (48%) of 129 gastric cancer tissues. EphA4 overexpression, at the protein level, was significantly associated with depth of invasion and recurrence. EphA4 overexpression was also correlated with FGFR1 overexpression. Patients with EphA4-positive cancer had significantly shorter overall survival periods than did those with EphA4-negative cancer (P = 0.0008). The mRNAs for ephrin ligands were coexpressed in various combinations in gastric cancer cell lines and cancer tissues. Downregulation of EphA4 expression by siRNA in EphA4-overexpressing gastric cancer cell lines resulted in a significant decrease in cell growth. CONCLUSION: Our results suggest that overexpression of EphA4 plays a role in gastric cancer.
Authors: V Davalos; H Dopeso; S Velho; A M Ferreira; L Cirnes; N Díaz-Chico; C Bilbao; R Ramírez; G Rodríguez; O Falcón; L León; R C Niessen; G Keller; G Dallenbach-Hellweg; E Espín; M Armengol; A Plaja; M Perucho; K Imai; H Yamamoto; J F Gebert; J C Díaz-Chico; R M Hofstra; S M Woerner; R Seruca; S Schwartz; D Arango Journal: Oncogene Date: 2006-07-03 Impact factor: 9.867
Authors: G C Jayson; C Vives; C Paraskeva; K Schofield; J Coutts; A Fleetwood; J T Gallagher Journal: Int J Cancer Date: 1999-07-19 Impact factor: 7.396
Authors: Hafid Alazzouzi; Veronica Davalos; Antti Kokko; Enric Domingo; Stefan M Woerner; Andrew J Wilson; Lars Konrad; Päivi Laiho; Eloi Espín; Manel Armengol; Kohzoh Imai; Hiroyuki Yamamoto; John M Mariadason; Johannes F Gebert; Lauri A Aaltonen; Simo Schwartz; Diego Arango Journal: Cancer Res Date: 2005-11-15 Impact factor: 12.701
Authors: E Y Shin; B H Lee; J H Yang; K S Shin; G K Lee; H Y Yun; Y J Song; S C Park; E G Kim Journal: J Cancer Res Clin Oncol Date: 2000-09 Impact factor: 4.553
Authors: E Kiyokawa; S Takai; M Tanaka; T Iwase; M Suzuki; Y Y Xiang; Y Naito; K Yamada; H Sugimura; I Kino Journal: Cancer Res Date: 1994-07-15 Impact factor: 12.701
Authors: Christian Hafner; Gerd Schmitz; Stefanie Meyer; Frauke Bataille; Peter Hau; Thomas Langmann; Wolfgang Dietmaier; Michael Landthaler; Thomas Vogt Journal: Clin Chem Date: 2004-01-15 Impact factor: 8.327
Authors: Haihui Lu; Karl R Clauser; Wai Leong Tam; Julia Fröse; Xin Ye; Elinor Ng Eaton; Ferenc Reinhardt; Vera S Donnenberg; Rohit Bhargava; Steven A Carr; Robert A Weinberg Journal: Nat Cell Biol Date: 2014-09-28 Impact factor: 28.824
Authors: Pierre Saintigny; Shaohua Peng; Li Zhang; Banibrata Sen; Ignacio I Wistuba; Scott M Lippman; Luc Girard; John D Minna; John V Heymach; Faye M Johnson Journal: Mol Cancer Ther Date: 2012-07-17 Impact factor: 6.261
Authors: Julia E Herrmann; Morgan A Pence; Emanuel A Shapera; Ravi R Shah; Cédric G Geoffroy; Binhai Zheng Journal: Genesis Date: 2010-02 Impact factor: 2.487